Continued Statin treatment after acute intracranial hemorrhage: Fighting fire with fire

Stroke

Volumn 44, Issue 7, 2013, Pages 2062-2063

  Molina, Carlos A ^a   Selim, Magdy H ^b  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

intracranial hemorrhage; statins; stroke recurrence

Indexed keywords

CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CLINICAL PRACTICE; HUMAN; MEDICAL DECISION MAKING; NOTE; PRIORITY JOURNAL; RISK ASSESSMENT; THROMBOCYTE AGGREGATION;

INTRACRANIAL HEMORRHAGE; STATINS; STROKE RECURRENCE;

ACUTE DISEASE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INTRACRANIAL HEMORRHAGES; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84879972116     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.113.001671     Document Type: Note

References (3)

1. The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006;355:549-559
2. Westover MB, Bianchi MT, Eckman MH, Greenberg SM. Statin use following intracerebral hemorrhage: a decision analysis. Arch Neurol. 2011;68:573-579
3. Haussen DC, Henninger N, Kumar S, Selim M. Statin use and microbleeds in patients with spontaneous intracerebral hemorrhage. Stroke. 2012;43:2677-2681.